跳至主要内容
临床试验/NCT04713228
NCT04713228终止不适用

Prospective Case-Control Study of Cardiovascular Changes in Pregnancy Related Hypertensive Disorders

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2021年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
12
试验地点
2
主要终点
Change in Systolic Function measured as Left ventricular ejection fraction (LVEF)

研究概览

简要总结

This is a research study to understand the changes in the heart and the cardiovascular system that may occur in women who develop high blood pressure during pregnancy.

详细描述

Upon Enrollment in this study, participants will go through two scans along with some blood test and other assessments. The first scan is a sonogram of the heart called an echocardiogram, and another scan is done using the investigational ARTSENS device that will be used to measure stiffness of the walls in the arterial blood vessel for indications of inflammation damage. ARTSENS device is not approved for use in the United States. It is expected that we will enroll 50 people in this study. The entire study is expected to last 2 years. Participation will be for approximately 9 months.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Case Inclusion Criteria:
  • Adult females age > 18 years
  • Must be able to read and understand English and consent for themselves
  • Must have a singleton pregnancy and a diagnosis of preeclampsia or gestational hypertension
  • Must be willing and able to come to West Penn Hospital for post-partum visits at 6-8 weeks and then at 6-7 months.

排除标准

  • Prior history of hypertension
  • Multiple pregnancies
  • Other comorbidities such as congenital heart disease, dialysis dependent renal failure, heroin abuse, cocaine abuse, pulmonary hypertension, congestive heart failure, autoimmune conditions such as SLE or severe lung disease.
  • Subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
  • Control Inclusion Criteria:
  • Adult females age > 18 years
  • Must be able to read and understand English and consent for themselves
  • Must have a singleton pregnancy and not have a prior or current diagnosis of hypertension
  • Must be willing and able to come to West Penn Hospital for post-partum visits at 6-8 weeks.
  • Control Exclusion Criteria:
  • Prior history and/or current diagnosis of hypertension
  • Multiple pregnancies
  • Other comorbidities such as congenital heart disease, dialysis dependent renal failure, heroin abuse, cocaine abuse, pulmonary hypertension, congestive heart failure, autoimmune conditions such as SLE or severe lung disease.
  • Subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.

结局指标

主要结局

Change in Systolic Function measured as Left ventricular ejection fraction (LVEF)

时间窗: 6 months

Measurement: LVEF is expressed as a % and Global longitudinal strain measurement also expressed as %. Measurements tools: two dimensional echocardiography and strain imaging with speckle tracking echocardiography

Change in Diastolic function

时间窗: 6 months

Measurement: E/E' velocity; This is a ratio and there is no unit for measurement. Measurement tools: Pulse Doppler echocardiography

Change in vascular compliance

时间窗: 6 months

Measurement: Pulse strain elasticity (Ep) expressed as kPa, Arterial stiffness Beta which is an index without units. Measurement tool: Arterial waveforms captured with the ARTSENS device

Change in vascular stiffness

时间窗: 6 months

Measurement: Beta which is an index without units Measurement tool: Arterial waveforms captured with the ARTSENS device

次要结局

  • Correlation of left ventricular ejection fraction (LVEF) with troponin and proBNP(3 months)
  • Correlation of vascular compliance and stiffness(3 months)

研究者

发起方
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
申办方类型
Other
责任方
Principal Investigator
主要研究者

Indu Poornima

Director, Section of Cardiovascular Prevention, AHN; Professor of Medicine, Drexel University College of Medicine

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

研究点 (2)

Loading locations...

相似试验

Prospective Case-Control Study of Cardiovascular... | 临床试验